Olink Holding (NASDAQ:OLK) Full Year 2023 Results

Key Financial Results

• Revenue: US$169.6m (up 21% from FY 2022).
• Net loss: US$31.6m (loss widened by 146% from FY 2022).
• US$0.26 loss per share (further deteriorated from US$0.11 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Olink Holding Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 12%. Earnings per share (EPS) also missed analyst estimates significantly.

Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Life Sciences industry in the US.

Performance of the American Life Sciences industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Olink Holding's balance sheet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.